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Abstract
The small GTPase Cdc42 is a key regulator of polarity, but little is known in mammals about its 
spatial regulation and the relevance of spatial Cdc42 pools for polarity. Here, we report the 
identification of a GM130-RasGRF complex as a regulator of Cdc42 at the Golgi. Silencing 
GM130 results in RasGRF-dependent inhibition of the Golgi pool of Cdc42, but does not affect 
Cdc42 at the cell surface. Furthermore, active Cdc42 at the Golgi is important to sustain 
asymmetric front-rear Cdc42-GTP distribution in directionally-migrating cells. Concurrently to 
Cdc42 inhibition, silencing GM130 also results in RasGRF-dependent Ras-ERK pathway 
activation. Moreover, depletion of GM130 is sufficient to induce E-cadherin down-regulation, 
indicative of a loss in cell polarity and epithelial identity. Accordingly, GM130 expression is 
frequently lost in colorectal and breast cancer patients. These findings establish a previously 
unrecognized role for the GM130-RasGRF-Cdc42 connection in regulating polarity and 
tumourigenesis.
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Introduction
Cell polarity is a highly orchestrated multi-step cellular process that regulates a plethora of 
biological functions of relevance for cell migration, wound healing and cancer. Among the 
regulators of polarity, the small GTPase Cdc42 is known to play a central role 1. Given the 
emerging role of polarity in tumourigenesis 2–4, it is now important to study the regulation 
of Cdc42 in time and space. A large body of evidence exists on Cdc42 signalling at or from 
the plasma membrane, but in comparison only little is known about Cdc42 signalling from 
endomembranes such as the Golgi apparatus, where this Rho family GTPase has been 
detected previously 5, 6. It currently remains unclear whether Cdc42 at the Golgi is 
regulated, what factors contribute to its activation and whether this pool is of any relevance 
for cell polarity. Endomembranes are increasingly recognized as sites where cellular signals 
are either initiated or modulated 7, thus supporting the notion that the Golgi pool of Cdc42 
might be biologically relevant. Furthermore, the Golgi apparatus is known to play a role in 
directional migration and polarity 8, but despite wide acceptance there is surprisingly little 
mechanistic understanding of the role of this organelle in directional motility and cell 
polarity. Therefore, investigating whether a Golgi protein regulates spatial Cdc42 signalling 
might provide mechanistic insight into the role of the Golgi in polarity.
RasGRF family Guanine Nucleotide Exchange Factors are well-known regulators of the 
small GTPase Ras 9, 10. In addition, RasGRFs were shown to mediate functional crosstalk 
between Ras signaling and Cdc42 11, 12. In this respect, it has been recently demonstrated 
that RasGRF binds to and inhibits Cdc42, thereby regulating cellular motility, 
transformation and invasion 13.
In the current work, we hypothesized that the Golgi matrix protein GM130 might regulate 
the activity of the Golgi pool of Cdc42. Using fluorescent reporters, we show that this is 
indeed the case. We identify, through siRNA screening of a guanine nucleotide exchange 
factor (GEF) library, candidate GEFs that contribute to the regulation of Cdc42 specifically 
at the Golgi, but surprisingly none of these is involved in regulating the GM130-Cdc42 axis. 
We go on to identify RasGRF2 as a novel interaction partner for GM130 and demonstrate 
that this interaction is pivotal for the regulation of both Ras and Cdc42. Loss of GM130 
releases RasGRF, allowing it to inhibit Cdc42 and activate Ras, leading to alterations in cell 
polarity and hyperactivity of the Ras-ERK pathway. Accordingly, we show that GM130 is 
frequently downregulated in cancer.
Results
The Golgi pool of Cdc42 controls cell polarity
To study spatial Cdc42 activation patterns we used a Cdc42 Raichu probe 14, 15. For all our 
measurements we used a probe containing the C-terminal domain of Cdc42 15 (Cdc42-EM 
hereafter). This C-terminal domain targets the FRET reporter to different membranes 
including the plasma membrane and various cellular endomembranes such as the Golgi and 
endosomes (Supplementary Fig 1A) localizing as reported for endogenous Cdc425. Cdc42-
EM appeared in a juxtanuclear pool colocalizing with GM130, indicating its presence at the 
Golgi complex (Fig. S1B), thus allowing us to monitor Cdc42 activation at this cellular 
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location where Cdc42 is active 6 (Fig. 1 A). Measuring FRET outside the Golgi-area or the 
plasma membrane did not reveal any specific signal, thus supporting the specificity of our 
FRET measurements (Fig. 1A). Silencing GM130 reduced the total cellular pool of Cdc42-
GTP 16 (Fig. S1C), and reduced substantially the activity of Cdc42 at the Golgi (Fig. 1B). 
However, GM130 depletion did not affect the activity of this reporter at the plasma 
membrane indicating that it did not affect Cdc42 activation therein (Fig. 1C). Silencing 
GM130 inhibited 2D cell migration (Fig S1E) indicating that alteration of spatial Cdc42 
signalling is relevant for directed cell motility. Moreover, the recruitment of aPKC to the 
leading edge of directionally migrating cells was also reduced (Supplementary Fig. 1F). To 
test for effects on polarity in a 3D cell culture model, we used Caco-2 cells, which are 
known to spontaneously polarize when plated in a 3D matrix, forming cysts with a single 
lumen. Previous work showed that alteration of Cdc42 activity (and thus of polarity) leads to 
the formation of multi-lumen (aberrant) cysts 17, 18. Depletion of GM130 in Caco-2 cells led 
to an increase in the number of aberrant cysts, which is indicative of a polarity defect (Fig. 
1D). These results suggested that regulation of spatial Cdc42 activity by GM130 was 
relevant for cell polarization in 2D and 3D cell culture. In contrast, GM130 depletion did not 
affect Golgi morphology (Supplementary Fig 2), ER-Golgi trafficking, Golgi-to-plasma 
membrane trafficking or coatomer recruitment to the Golgi (Supplementary Fig. 3A–C). 
Furthermore, the capability of the Golgi to nucleate microtubules was also unaffected 
(Supplementary Fig. 3D), in agreement with previous findings 19. Thus, the indirect impact 
of these processes on polarity could be excluded 8.
Directed trafficking causes asymmetric distribution of Cdc42
To obtain direct evidence for the role of the GM130-regulated Golgi pool of active Cdc42, 
we measured Cdc42 activity at the front and the rear of directionally migrating cells using 
the Cdc42-EM probe. Strikingly, Cdc42 activity exhibited an asymmetric distribution, being 
more active at the front compared to the rear of the cell (Fig. 1E, F). Silencing GM130 
reduced the amount of activated Cdc42 at the leading edge, thereby breaking the asymmetric 
distribution of active Cdc42 (Fig. 1E, F). These results were confirmed by 
immunofluorescence staining of endogenous Cdc42-GTP (Fig. 1G). Sustained accumulation 
of active Cdc42 at the leading edge could be the consequence of an increased local 
activation. Alternatively, the Golgi might deliver Cdc42-GTP to the leading edge. If the 
latter mechanism was true, then blocking trafficking from the Golgi ought to diminish the 
amount of Cdc42-GTP at the leading edge. To investigate this point, directionally migrating 
cells in a wound closure assay were incubated at 20°C for one hour, which blocks exit from 
the trans-Golgi 20. Measuring FRET reporter activity or staining for Cdc42-GTP revealed 
that blocking post-Golgi trafficking diminished the presence of GTP-Cdc42 at the cell front, 
thereby abolishing Cdc42-GTP asymmetry (Fig. 1E&F). Importantly, re-incubation of the 
cells at 37°C for one hour re-established Cdc42-GTP asymmetry with higher levels at the 
leading edge compared to the rear (Fig. 1F). The loss of Cdc42-GTP asymmetry in GM130 
knockdown cells was likely due to abrogation of directed trafficking. Live cell imaging of 
GFP-VSVG tracks forming from the Golgi showed that while carriers formed readily in 
GM130-depleted cells, they were non-directed, contrarily to tracks in control cells, which 
mostly trafficked towards the leading edge (Fig. 1H). Of note, the directionality of post-
Golgi trafficking was affected, whereas the global rate of post-Golgi trafficking was not 
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(Supplementary Fig. 3B). Since, both GDP- and GTP-restricted Cdc42 is known to block 
post-Golgi trafficking 21 we conclude that GM130 depletion does not affect the GTP/GDP 
cycling of Cdc42. Taken together, the Golgi pool of active Cdc42 is relevant for cell 
polarization.
The GM130-Cdc42 crosstalk does not involve GEFs
Next we asked how the Cdc42 activity at the Golgi was regulated by GM130. One 
possibility is that GM130 recruited a Cdc42 GEF leading to local activation of this GTPase. 
If true, then this GEF must interact with GM130 and localize to the Golgi in a GM130-
dependent manner (schematic in Fig. 2).
To identify GEFs that contribute to activate Cdc42 at the Golgi, we screened a library of 51 
siRNAs against Rho family GEFs for effects on the Golgi pool of Cdc42 using the Cdc42-
EM FRET probe. We focused primarily on the knockdowns that affected Cdc42 activity at 
the Golgi in a manner more conspicuous than GM130 depletion. While several GEF 
knockdowns decreased the FRET values at the Golgi, only three had an effect that was 
comparable to the effect of GM130, namely ARHGEF9, 11 and 12 (Fig. 3A). Depletion of 
GEF11 and 12 also resulted in reduced total cellular Cdc42-GTP (Supplementary Fig. 4B) 
supporting these FRET measurements. Depletion of any of these GEFs also resulted in an 
inhibition of directed migration as determined in a wound-healing assay (Supplementary 
Fig. 4C). In addition, polarization of the Golgi to the leading edge of migrating cells was 
also affected (Supplementary Fig. 4D). However, none of these GEFs interacted with 
GM130 in co-immunoprecipitation experiments, nor did they localize to the Golgi (Fig. 3B, 
C). We also failed to detect any evidence for an involvement of the GEF Tuba, as it did not 
localize to the Golgi (Fig. S5A, B), nor did it interact with GM130 (Supplementary Fig. 5C, 
D) contrarily to previous findings 16, and in agreement with others who failed to detect this 
GEF at the Golgi 22, 23. In addition, neither Tuba depletion (Fig 3A, Fig S5E) nor its 
overexpression (Supplementary Fig. 5F) changed the activation of Cdc42 at the Golgi. Of 
note, none of the GEFs tested localizes to the Golgi (Oliver Rocks, personal 
communication). Therefore, the GM130-Cdc42 crosstalk was not mediated via recruitment 
of a GEF driving local activation of Cdc42.
The GM130-Cdc42 crosstalk involves RasGRF
Another explanation for the GM130-Cdc42 connection could be that GM130 was preventing 
the function of some Cdc42 inhibitor (schematic in Fig. 2). One possible candidate was the 
GEF RasGRF2, the RasGRF isoform expressed in epithelial cells, which has been recently 
shown to act as an inhibitor of Cdc42 13. A marked association of endogenous GM130 and 
RasGRF2 could be detected in co-immunoprecipitation experiments (Fig. 4A). Moreover, in 
about 50% of the cells, RasGRF2 co-localized with GM130 at the juxtanuclear region, 
consistent with Golgi complex localization (Fig. 4B, C). RasGRF in addition also exhibited 
a localization pattern reminiscent of the ER, which is in agreement with previous work 24. 
Noticeably, upon GM130 depletion, RasGRF2 juxtanuclear localization dropped strongly to 
less than 10% of the cells (Fig. 4B, C). Moreover we found that the interaction between 
these proteins was mediated by the C-terminal domain of GM130 and the Cdc25 domain of 
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RasGRF2 (Supplementary Fig. 6A& B). These data suggested that GM130 is involved in 
localizing RasGRF to the Golgi complex.
Overexpression of RasGRF1 or 2 blocked activation of Cdc42 at the Golgi as determined 
using the Cdc42-EM probe, in a manner dependent on the GEFs DH domain (Fig. S6C). 
Importantly, co-knockdown of GM130 and RasGRF2 restored Cdc42 activation levels at the 
Golgi (Fig. 1A). The involvement of RasGRF in the GM130-Cdc42 crosstalk was further 
supported by the finding that GM130 depletion did not affect the levels of GTP-Cdc42 in 
CHL cells which naturally lack all RasGRF isoforms (Fig. 4D). Therefore, we conclude that 
RasGRF is an essential mediator in the GM130-Cdc42 crosstalk.
Regulation of the GM130-RasGRF complex
We hypothesized that GM130 could sequester RasGRF, thereby preventing it from binding 
and inhibiting Cdc42. Thus, under conditions that activate Cdc42, GM130 would sequester 
RasGRF to prevent it from inhibiting Cdc42. To test this hypothesis, we determined whether 
the GM130-RasGRF complex is affected by serum-starvation, a condition under which 
Cdc42 is not activated. Under these conditions, GM130 did not co-immunoprecipitate with 
RasGRF (Fig. 5A), contrary to cells in steady-state cultured under complete conditions (Fig. 
3). Treatement with 10% FCS for 10 min resulted in re-formation of the GM130-RasGRF 
complex (Fig. 5A). If RasGRF were free under serum-starved conditions, then we would 
expect the Golgi pool of Cdc42 to be unresponsive to GM130 depletion. Cdc42 at the Golgi 
responded to serum treatment in control siRNA transfected cells, while GM130 depleted 
cells did not respond to this treatment (Fig. 5B). Of note, the FRET values at the Golgi were 
similar in control and GM130 silenced serum-starved cells, further supporting the notion 
that this pool becomes GM130-independent under serum-starved conditions (Fig. 5B).
If GM130 acts to protect Cdc42 from inhibition by RasGRF, then depletion of GM130 ought 
to increase the association between RasGRF and Cdc42. Co-immunoprecipitation 
experiments demonstrated that this was the case: the amount of RasGRF in association with 
Cdc42 increased in GM130 knockdown cells compared to control cells (Fig. 5C).
Finally, we tested whether RasGRF is relevant for the GM130-Cdc42 crosstalk in the 
context of polarity. This was the case, as co-depletion of RasGRF2 and GM130 rescued the 
polarity defects imposed by GM130 depletion (Fig. 3F&G).
The GM130-RasGRF complex controls Ras activity
Our data indicated that GM130 acts as a repressor of RasGRF. Consistent with this model 
(Fig. 6A), knockdown of GM130 would release RasGRF, allowing it to inhibit Cdc42. 
However, RasGRF is also a well-known activator of Ras. Thus, in agreement with our 
model, loss of GM130 should also result in an increase of Ras activation. To test this 
prediction, we performed a knockdown of GM130 and measured Ras activation using a 
pulldown assay. Depletion of GM130 increased the levels of GTP-loaded Ras and co-
knockdown of RasGRF abolished this effect (Fig. 6B), indicating that the increase in Ras 
activity was dependent on RasGRF. We also tested whether signalling downstream of Ras 
was modulated at the level of ERK1/2 in response to mitogen treatment. Knockdown of 
GM130 increased ERK1/2 activation in response to serum stimulation and this effect was 
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again dependent on RasGRF (Supplementary Fig. 7A). To test whether the effect on 
ERK1/2 signaling is biologically relevant, we depleted GM130 in PC12 cells. These cells 
are a standard model for ERK-dependent cell fate decisions 25. Higher and more sustained 
ERK1/2 signalling increases the likelihood that PC12 cells shift from proliferation to 
differentiation, which is evident by the emergence of neurites. Depletion of GM130 resulted 
in elevated and sustained ERK1/2 activation (Supplementary Fig. 8A) and accordingly the 
percentage of cells that underwent differentiation was significantly increased 
(Supplementary Fig. 8B&C). Thus, the effects of GM130 on Ras signalling are relevant for 
ERK-dependent cell fate decisions.
Expression of GM130 in colon cancer
Loss of polarity is a frequent feature of epithelial tumours and is associated with dysplasia 
and increased metastatic potential 3, 4. Our results indicated that GM130 regulates polarity 
by modulating the Golgi pool of active Cdc42 and, in addition, Ras activity. Therefore, we 
asked whether GM130 might be associated with the malignant phenotype. To investigate 
this possible connection, we used two strategies. First, we analysed GM130 expression in a 
colon cancer progression TMA comparing normal colon mucosa (29 cases), adenoma (16 
cases), and adenocarcinoma (109 cases) (Fig 7A). While the expression of GM130 only 
differed marginally in normal colon and adenoma, the expression in carcinoma was reduced 
markedly (Fig. 7B–D). We next extended this analysis in samples from 16 patients, present 
on TMA, with matched normal and cancer tissues. We compared the scored intensity of 
GM130 expression and found that in 14 out of 16 individual patients the expression of 
GM130 was reduced in tumours compared to the matched normal tissue (Fig. 7E&F). The 
down-regulation of GM130 in cancer was further confirmed by an analysis of 11 matched 
normal and cancer colon tissues from a different source (Supplementary Fig. 9). In this case, 
the intensity of the GM130 staining was measured and healthy tissues were compared with 
the matching cancerous tissues. In agreement with the previous results, GM130 was down-
regulated in the cancerous tissue in 9 out of 11 patients (Supplementary Fig. 9A–C).
In support for a role of GM130 loss in tumour progression, we found that knockdown of 
GM130 in Caco-2 cells led to a loss of E-cadherin expression (Supplementary Fig. 9D), a 
phenotype that is often considered to be linked to tumour progression and a loss of epithelial 
identity and is in line with the notion that loss of polarity is a typical phenomenon in 
EMT 26. We could show that the effect of GM130 on E-Cadherin was not cell line specific, 
as the depletion of GM130 also caused loss of E-Cadherin in another epithelial cell line 
(Supplementary Fig. 9D).
Discussion
A large body of research on directional migration and cellular polarization has focused on 
dissecting signaling events that originate from and are regulated by proteins at the plasma 
membrane. However, comparatively little is known about how polarity is regulated by 
signaling from endomembrane compartments like the Golgi apparatus. This organelle was 
shown to orient towards the leading edge in directionally migrating cells 27 and disrupting 
Golgi structural integrity resulted in a block of directional motility 8. Our aim was to explore 
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the functional relevance of the Golgi localized pool of Cdc42 5. Overall, our data establish 
for the first time a role for active Cdc42 at the Golgi in the control of cell polarity and that 
the complex formed by GM130 and RasGRF is critical in this process. Of note, depletion of 
GM130 did not disrupt Golgi integrity or membrane trafficking, which is in agreement with 
others 28, 29. Different findings by others 30–32 can be attributed to the use of different cell 
lines, different siRNA concentrations and transfection reagents. We interpret our data to 
mean that the Golgi might supply the leading edge of migrating cells with active Cdc42. An 
alternative explanation could be that the Golgi is supplying the leading edge with a GEF for 
Cdc42, and recent work has already speculated about such a possibility 33. However, such a 
model cannot explain our data showing that co-depletion of RasGRF2 and GM130 rescues 
Cdc42 activation and cell polarity, which strongly implies that the presence of active Cdc42 
at the Golgi is important for polarization. Thus, we consider it more likely that active Cdc42 
is delivered from the Golgi to the leading edge. The Golgi could provide a permissive 
environment for accumulating active Cdc42 by being free or poor in GAPs. In fact, no Rho 
family GAPs were have been found at the Golgi, except for small amounts of 
ARHGAP21 34 (Oliver Rocks, personal communication).
Recent computational modelling approaches tried to elucidate the contribution of polarized 
trafficking to polarization in yeast 35–37. While trafficking appeared to be an important 
component, endocytic removal of Cdc42 from the leading edge, its lateral diffusion and ‘off’ 
kinetics from membranes were also found to be a key factor. This is in line with published 
work where directional polarity was found to be dependent on Arf6 33 a GTPase known to 
regulate endocytosis 38.
Altogether, our findings establish for the first time a connection between endomembrane 
Cdc42 activity and cell polarity and allow us to propose a role for this regulation in 
neoplasia. The GM130-RasGRF-Cdc42 axis appears as a potentially valuable new 
therapeutic target and future work will elucidate whether the loss of GM130 observed in 
tumours is associated with a change in the invasive or metastatic potential of cancer cells.
Methods
Cell Culture and transfection
HeLa, HEK293, HepG2, MCF7 cells were purchased from ATCC and were cultured in 
Dulbecco’s modified Eagles medium (DMEM) supplemented with 10% FCS and 100 U/ml 
penicillin/streptomycin. RPE-1 cells were grown in DMEM/F12 supplemented with 10% 
FCS and 100U/ml penicillin/streptomycin. MDA-MB-231 were cultured in RPMI 
supplemented with 10% FCS and 100 U/ml penicillin/streptomycin. PC12 cells were 
cultured in RPMI supplemented with 10% HS, 5% FCS and 100U/ml penicillin/
streptomycin. Caco-2 cells were cultured in minimal essential medium supplemented with 
20% FCS and 100 U/ml penicillin/streptomycin. To generate stable cell lines, cells were 
transduced with lentiviruses (produced according to the protocols of Trono’s lab) and 
transduced cells were either selected with antibiotics or sorted via FACS. Transfection of 
siRNA was performed using HiPerFect (Qiagen) or Lipofectamine2000 (Invitrogen) 
according to the manufacturer’s instructions. The siRNAs used for the GEF screening were 
purchased from Thermo Fisher Scientific. Control siRNA was purchased from Thermo 
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Fisher Scientific (ON_TARGETplus Control pool – Cat. Nr. D-001810-10-20). The siRNAs 
against GM130 were from Thermo Fisher Scientific (ON-TARGETplus smart pool – Cat. 
Nr. L-017282-00 – indicated in the text as siRNA1) and from QIAGEN (SI04235147 - 
indicated in the text as siRNA2 – and SI00429191, indicated in the text as siRNA3). The 
siRNA against RasGRF2 was from Qiagen (SI04329941). The siRNA against TUBA was 
from QIAGEN (SI04220237 – used in Fig 1B). Plasmid transfection was performed using 
Fugene6 (Promega) according to the manufacturer’s instructions. Cells were typically 
transfected 24 h prior to the experiment. PC12 cells were transfected with FugeneHD 
according to the manufacturer’s instructions.
Plasmids
Cdc42-GFP-wt (nr. 12599), Cdc42-GFP-TN (nr. 12601), Cdc42-GFP-QL (nr. 12600) were 
from Addgene (Klaus Hahn’s Laboratory6). RasGRF1-HA, RasGRF2-FLAG, RasGRF1-
ΔPH-DH, RasGRF1ΔCdc25, RasGRF2-ΔDH and RasGRF2-ΔCdc25 were described 
previously13. myc-GM130-ΔN690 was cloned using pcDNA 3.1 myc-His as backbone pL-
Venus-Cdc42 was cloned using a modified version of pLVTHM as backbone. RAICHU-
Cdc42-EM and RAICHU-Cdc42-PM were kind gifts from Dr. Michiyuki Matsuda (Kyoto 
University, Japan). The RUSH-MannII-GFP expressing HeLa cells, as well as the VSVG-
GFP-RUSH plasmid were a kind gift from Dr. Franck Perez39. Temperature-sensitive 
VSVGts045-GFP was a kind gift from Dr. Kai Simons. Flag tag ARHGEF9, 11 and 12 were 
a gift from Dr. Oliver Rocks. Lentiviral packaging plasmids were bought from Addgene 
(psPAX2 nr. 12260, pMD2.G nr. 12259 and pLVTHM nr. 12247, from Didier Trono’s 
laboratory). GM130 GIPZ shRNA was bought from Thermo Scientific (Clone ID: 
V3LHS_313361). GM130 rat shRNAs (RSH050521 nr 1 to 4) and Control shRNAs 
(MSH029723-CH1) were bought from Genecopoeia. pmTurquoise2-Golgi was from 
Addgene (nr. 36205 40).
Pull-down experiments
To pull down active Cdc42 cells were lysed in buffer (25mM HEPES pH7.5, 150mM Nacl, 
1% Nonidet-P-40, 10mM MgCl2). Purified GST-tagged effector domain of PAK1 
immobilized on GSH-sepharose beads was added to the lysate that was pre-cleared by 
centrifugation at 21,000xg for 5 min at 4°C. After 1 h incubation at 4 °C, beads were washed 
twice followed by boiling in sample buffer to elute bound material.
To precipitate active Ras, the same procedure was used with the exception the purified GST-
tagged Raf1-RBD immobilized to GSH-sepharose beads were added to the lysate.
ERK1/2 activation assays
250,000 HeLa or HEK293 cells were plated in 35mm dishes and transfected with siRNA at 
the same time (HiPerFect from Qiagen). After 72h cells were serum-starved for at least 2 h. 
Cells were subsequently stimulated with 10% FCS followed by lysis in ice cold MAPK 
buffer (150mM NaCl 20mM TRIS-HCl pH7.5, 1% Triton X-100) supplemented with 
protease and phosphatase inhibitors. The amount of phosphorylated ERK1/2 was determined 
by immunoblotting.
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PC12 differentiation
PC12 cells were plated at low density on Collagen-coated coverslips. 24 h later, cells were 
transfected with plasmids encoding either control shRNA or GM130 shRNA. Cells were 
then serum starved overnight. Cells were then stimulated with 10% NGF and 1% HS for 
48h, then coverslips were stained and fixed. Cells with neurites as long as the body length 
were scored as ‘differentiated’. Due to the presence of GFP in the plasmid encoding for the 
shRNAs, we were able to count only cells effectively transfected. To measure P-ERK 
intensity, cells were stimulated as described above for 0, 30 or 90 minutes and then stained.
Antibodies and immunofluorescent labels
Rabbit monoclonal anti-Cdc42 (dilution 1:300 – Cat. Nr. 2466), rabbit polyclonal ERK1/2 
(dilution 1:1000 – Cat. Nr. 4695) and rabbit polyclonal against phospho-ERK1/2 (dilution 
1:1000 – Cat. Nr. 9101) were purchased from Cell Signalling. Mouse monoclonal GTP-
Cdc42 was purchased from NewEast Biosciences (dilution 1:50 - Cat. Nr. 26905). To stain 
for GTP-Cdc42, Image-iT, FX Signal Enhancer from Invitrogen was used according to 
manufacturer’s instructions. Mouse monoclonal anti-GM130 antibody was from BD-
Biosciences (IF dilution: 1:1000 – WB dilution 1:250 – Cat. Nr. 610823). Rabbit 
monoclonal anti-GM130 was from cell signalling (dilution 1:500 – Cat. Nr. 12480). Rabbit 
monoclonal anti-RasGRF (WB dilution 1:200 – IF dilution 1:50 – Cat. Nr. Sc-863) and 
Mouse monoclonal E-Cadherin antibody (dilution 1:500 – Cat. Nr. 21791) were purchased 
from Santa-Cruz. Rabbit polyclonal anti-Giantin antibody was from Covance (dilution 
1:1000 – Cat. Nr. PRB-114C). Monoclonal ANTI-FLAG® M2-Peroxidase (HRP) was from 
Sigma (dilution 1:2000 – Cat. Nr. A8592). Mouse monoclonal anti-HA 12CA5 antibody was 
from Roche (WB dilution 1:4000 – IF dilution 1:500 – Cat. Nr. 11583816001). Mouse 
monoclonal anti-γ-tubulin (dilution 1:1000 – Cat. Nr. Ab11317), Rabbit polyclonal anti 
TGN46 (dilution 1:1000 – Cat. Nr. Ab50595) were from Abcam, Mouse monoclonal anti-
GFP (dilution 1:1000 – Cat. Nr. 11814460001) was from Roche. AlexaFluor647 Phalloidin 
(Cat. Nr. A22287) and AlexaFluor488 concanavalin (Cat. Nr. C11252) and 
AlexaFluor647HPA (Cat. Nr. L32454) were from Invitrogen. For immunofluorescence 
staining cells were grown on glass coverslips. To stain for RasGRF, cells were fixed on ice 
with 4% formaldehyde for 10 min followed by permeabilization with PBS containing 0.05% 
triton X100 for 3 min at RT. To stain for β-COP cells were fixed with methanol-acetone 
(50/50) for 2 min on ice. For all other stainings, cells were fixed with 4% paraformaldehyde 
for 15 min at RT followed by permeabilization with PBS containing 3% BSA and 0.2% 
triton X100.
Microtubule nucleation assay
RPE-1 cells were plated on coverslips and transfected with siRNAs using HIPerFect. After 
72 h, 0.1 mM HEPES pH 7.35 was added to the cells and the cells were then transferred on 
ice for 40 minutes. Then cells were put back at room temperature and fixed after 0, 3 and 4 
minutes at room temperature in fixation/permeabilization buffer (10mM Citric Acid, 0.05% 
Tween 20, pH 6.0, PFA 2% in buffer CB, 0,025% glutaraldheide, 0,2% Tx-100). 
Immunostaining was then performed using antibodies against GM130, TGN46 and Tubulin.
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Caco2 Cysts
Caco-2 cells were plated in 35mm dishes. 24 h later they were transfected with siRNAs 
using Lipofectamine 2000. After an additional 24 h cells were trypsinized and an additional 
siRNA transfection using Lipofectamine 2000 was performed. Cells (6×104) were re-
suspended in 60% DMEM + 40% Matrigel (previously thawed overnight on ice). 100ul of 
this solution was plated into 8-wells chambers (BD-biosciences), incubated at 37°C for 30 
minutes and, once solid, Matrigel was covered with 400ul of DMEM. Media was changed 
every other day. On the 4th day of culture cysts were fixed with 300ul of paraformaldehyde 
(4%) 30 min at RT, washed with PBS, permeabilized with 0.5% triton X-100 for 10 min and 
washed with PBSG (PBS containing 7.5mg/ml glycine). Non-specific staining was blocked 
with 300ul of blocking buffer (7.7mM NaN3, 0.1% BSA, 0.2% Triton X-100, 0.05% 
Tween20) and afterwards the 8-wells chambers were incubated overnight with the primary 
antibodies diluted in PBS containing 3% BSA. On the next day, cells were washed with 
blocking buffer and secondary antibodies + fluorescent phalloidin were added for 2 h at RT. 
Cells were washed again with blocking buffer and the plastic support was removed. A glass 
coverslip was put on the top of the matrigel and the samples were imaged.
Confocal microscopy image analysis and FRET
Microscopy was performed on a LeicaSP5 confocal laser-scanning microscope equipped 
with a Ludin chamber. Most imaging was performed using the 63X objective (1.4 NA). 
Images were converted into TIFF files and analysed using ImageJ. FRET was performed 
using the donor-recovery after acceptor photobleaching method using the FRET-AB wizard 
of the Leica software. Acceptor (YFP) fluorescence was bleached at 100% laser intensity 
assuring a minimal extent of bleaching by 75%. To analyse FRET at the Golgi, we chose a 
region in the juxtanuclear region where the reporter accumulated. To test whether we could 
recognize the Golgi correctly when looking at the reporter, we initially performed 
experiments where we colocalized the reporter with Golgi markers and found that we could 
always recognize the Golgi accurately. To measure FRET at the plasma membrane, we 
chose random regions at the plasma membrane of cells grown up to 80% confluency. 
Briefly, cells were divided into 4 regions (quadrants of a Cartesian Coordinates Plane) and 
FRET was measured every time in one different region (the first cell was measured in the 
first quadrant, the next cell in the second quadrant, and so on). The only limitation we 
imposed was to avoid regions overlapping with neighbor transfected cells. ImageJ was used 
to process the images. Briefly, the process “subtract background” was used on every image. 
If needed to improve visibility, brightness and contrast of the images were corrected 
(linearly) using the “adjust” menu of ImageJ. Images coming from the same experiment 
were all modified the same way to leave unaltered the information. Merged images were 
created with the appropriate function of ImageJ, after correcting the single channel images 
as described above.
GEF screening
FRET measurements at the Golgi were performed in HEK293 cells expressing the Cdc42-
EM probe. We calculated the CI95 of GM130 knockdown vs. control cells according to:
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Any value below the CI95 (red line in Fig. 2) was considered a hit. Our previous 
measurements of control and GM130 knockdown cells were used to quantitate the CI95 with 
the formula described above. 30–45 cells were measured for each condition from two-three 
independent experiments. The rationale for measuring at least 30 cells was based on our 
calculation that 18 data points (i.e. cells) are necessary to distinguish a population that 
differs from the control by 80% of the GM130 effect.
FRET of directional migrating cells
HeLa cells were plated on glass coverslips and transfected with siRNA (HIPerfect). After 48 
h, cells were transfected with plasmids encoding Cdc42-EM or Cdc42-PM FRET probes 
(Fugene6). After 72 h, a wound was made using a 200μl pipette tip and cells were allowed to 
migrate at 37°C for 6 hours. Then cells were either fixed or incubated for 1 h at 20°C and 
subsequently fixed. To measure FRET, we selected the region of the cells directly facing the 
wound and named it “front”. For regions designated as “rear” we chose regions from the 
side of the cell opposing the wound. Up to 3 different regions were measured in the “rear” 
and averaged. We did not detect any dependency on where we measured as long as the 
plasma membrane was opposing the wound. We avoided measuring FRET in regions 
overlapping with neighbor transfected cells.
Video acquisition of VSVG-GFP vesicles
HeLa cells were plated on glass coverslips and transfected with siRNA (HIPerfect). After 48 
h, cells were transfected with plasmids encoding for the VSVG-GFP-RUSH (Fugene6). 
After 72 h, a wound was made using a 200μl pipette tip and cells were allowed to migrate at 
37°C for 4 hours. Then imaging was started and biotin added to release the VSVG construct 
from the ER. Images were acquired every 1.5 sec.
Golgi orientation, cell migration and aPKC recruitment assay
For Golgi orientation assays, cells were plated on glass coverslips. After 72 h, a wound was 
made manually using a 200μl pipette tip. Cells were stained with antibodies anti γ-tubulin 
and anti-giantin immediately after wounding and after 6 hours. For assays measuring aPKC 
recruitment to the leading edge, cells were fixed 1 h after wounding.
For migration assays, cells were transfected with siRNA, and trypsinized after 48 h and 
plated into Ibidi® chambers placed on glass cover slips. This insert consists of two 
chambers separated by a 600 μm wall. Removal of the insert generates a wound with a 
defined width of 600 μm. 12000 cells were plated into each chamber. After 6h, the IBiDi 
insert was removed and cells were allowed to migrate at 37°C for 24 h. Then, cells were 
fixed and stained with concanavalin-alexa 488.
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Coimmunoprecipitations
1×106 cells were plated in 10cm2 cell culture dishes. After 24 h, cells were transfected. After 
an additional 24 h, cells were lysed in IP buffer (20mM HEPES pH 7.3, 200mM KCl, 0,5% 
Triton X-100), then centrifuged for 15 min at 20’000xg. The supernatant was incubated with 
protein G sepharose beads coupled to the appropriate antibodies. For anti-HA 
immunoprecipitation commercial anti-HA beads (Sigma) were used. After 2 h incubation at 
4°C, beads were recovered by centrifugation, washed and the bound material was eluted by 
boiling in sample buffer.
RUSH assay to study ER-Golgi trafficking
The RUSH assay was performed as described previously 39. Briefly, 250,000 HeLa cells 
stably expressing RUSH-ManII-GFP were plated in 35mm cell culture dishes and 
transfected with siRNA (using HiPerFect from Qiagen). After 72 h, cells were either fixed 
directly or were treated with 40 μM of biotin for 1 h followed by fixation in 4% 
paraformaldehyde at RT.
RT-PCR
Total RNA was isolated from cells by using the Qiagen RNeasy kit. cDNA was prepared 
from 100ng total RNA by using the high capacity cDNA reverse transcription kit (Applied 
Biosystems) following manufacturers’ instructions. Q-PCR was performed by using Fast 
SYBR green PCR MasterMix (Applied Biosystems). RT-PCR were run on 7900HT Fast 
RT-PCR system (Applied Biosystems). Expression of each gene was normalized to the 
expression of ubiquitin and β-2-microglobulin. Specific primers for RasGRF2 were 
described in Jacinto et al. 41. Primers for TUBA, ARHGEF9, ARHGEF11 and ARHGEF12 
were designed using PrimerExpress®.
Immunohistochemistry
Three-μm slides cut from three different tissue microarray block containing a total of 229 
different formalin-fixed, paraffin-embedded samples from colorectal cancers (n=133), 
tubulovillous adenomas (n=27) and normal colonic mucosa (n=69) were used (duplicate 
cores for each samples). The project was approved by the ethical committee of the IEO. 
Samples were rehydrated through xylene and graded alcohols. Antigen retrieval was 
accomplished using 1 mM EDTA, 0.05% Tween. After peroxidase block with 3% H2O2 for 
5 min, and block with 2% goat serum in PBS for 1 h, samples were incubated with primary 
antibodies (Mouse monoclonal anti-GM130 antibody, BD-Biosciences) in a 1:50 dilution for 
60’ min at RT in 2% goat serum. Immunocomplexes were visualized by the EnVision™+ 
HRP Rabbit (DAKO, K4011), and acquired with the Aperio ScanScope system. Duplicate 
cores for every sample were evaluated and then the scores were averaged and considered as 
weak expression (average score 0.5 – 1), moderate expression (average score 1.5 – 2), strong 
expression (average score 2.5 – 3), or as negative if they scored 0. IHC data for GM130 
expression were available only for 29 normal colonic mucosa, 16 tubulovillous adenoma and 
109 colorectal cancer samples, since in some cases, individual cores detached from the 
slides during the manipulations.
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11 matched colon cancer samples were analysed at the University of Regensburg according 
to the following procedure: two-μm slides cut from a tissue microarray block containing 60 
different formalin-fixed, paraffin-embedded samples from colorectal cancers (n=20) and 
matched normal tissues (n=40) were used. Immunohistochemistry of GM130 was carried 
out in a BenchMark ULTRA (VENTANA) autostainer according to the manufacturer’s 
instructions. Briefly, retrieval was done using a citrate buffer (pH 6.0) for 44 min. The anti-
GM130 antibody was used in a 1:100 dilution and incubated for 32 min. The slides were 
detected using the ULTRA View DAB detection kit (VENTANA). Negative controls 
without primary antibody were included in each experiment.
Statistical analysis
The data were analysed using Student T Test, Chi Square test or ANOVA test for multiple 
comparison in GraphPad Prism. All IF images are representative of at least 3 independent 
experiments. Western blots evaluations and IF evaluations are averages of at least 3 
independent experiments. For TMA analysis differences between experimental groups were 
examined for statistical significance using the nonparametric comparisons for each pair 
using Wilcoxon Method (Figure 7B) or Pearson Chi Square test (Figure 7C). Where 
applicable, data are expressed as average ± SD. TMA data analysis were performed using 
JMP 10.0 statistical software (SAS Institute, Inc).
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Figure 1. GM130 spatially regulates Cdc42 activity to control polarity
(A) One representative HEK293 cell transfected with the Cdc42-EM FRET reporter is 
shown. Areas where FRET was measured are marked in red and average FRET values ± 
standard deviation calculated from 5 independent experiments in control-transfected cells 
are shown. Scale bar = 25 μm. (B, C) HEK293 cells were transfected with the indicated 
siRNA. After 48h, cells were transfected with the Cdc42-EM FRET reporter. After 
additional 24 h, cells were fixed and FRET at the Golgi region (B) or at the plasma 
membrane (C). Averages of at least 3 independent experiments ± standard deviations (at 
least 15 cells per condition in every experiment) are shown on the graph. Asterisks indicate 
statistically significant differences tested using ANOVA with Newman-Keuls multiple 
comparison test (*p<0.05). (D) Caco-2 cells were transfected with the indicated siRNA. 
Cells were grown in Geltrex® matrix for four days and cysts were stained for Giantin (red) 
and GM130 (green) using immunofluorescence and for F-actin (blue) using fluorescent 
phalloidin. A magnification of a single cyst is displayed in the upper row and an overview of 
several cysts in shown in the lower row. Scale bar = 7.5 μm for the magnified images (upper 
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images) and 75 μm for the overview images. (E) HeLa cells were transfected with the 
indicated siRNA. After 48 h, cells were transfected with a plasmid encoding the Cdc42-EM 
Raichu probe. After 24 h, a wound was generated using a 10 μl pipette tip and cells were 
allowed to migrate and polarize for approximately 6 h at 37°C followed by fixation. 
Representative images of cells expressing the Raichu probe that are facing the wound are 
shown. FRET was measured on the plasma membrane part facing the wound (indicated as 
“Front”) and on the opposing end of the cell (indicated as “Rear”). Scale bar is 10 μm. (F) 
Graphic representation of FRET measurements from three independent experiments of HeLa 
cells expressing the indicated Raichu probe and that that were transfected with the indicated 
siRNA 72 h prior to the experimental measurements. Above the graph a schematic of the 
experimental setup: control cells have Cdc42-GTP at the Golgi and deliver it to the leading 
edge in a polarized way. GM130 knockdown cells have less Cdc42-GTP at the Golgi and 
lose the ability to polarize their traffic towards the leading edge. Blocking post-Golgi traffic 
by incubation at 20°C abolishes front-rear asymmetry and re-warming the cells to 37°C re-
established asymmetry. White bars represent Front/Rear ratios of FRET values. Results are 
means ± SD from four independent experiments. Asterisks indicate statistically significant 
differences tested using ANOVA with Newman-Keuls multiple comparison test (** 
p<0.01). (G) HeLa cells were transfected with siRNA. After 72 hours, a wound was made 
with a 10 μl tip and the cells were allowed to migrate for 6 hours. Cells were then fixed and 
immunostained for Giantin and Cdc42-GTP. Intensities of Cdc42-GTP were measured and 
the Front/Rear ratio is plotted as a bar graph. Results are means ± SD of 3 independent 
experiments. Asterisks indicate statistically significant differences tested using ANOVA 
with Newman-Keuls multiple comparison test (** p<0.01). Scale bar = 25 μm. (H) HeLa 
cells were transfected with the indicated siRNA. After 48 h, cells were transfected with the 
plasmid encoding for VSVG-RUSH-GFP. After further 24 h, a wound was made with a 10 
μl tip and cells were allowed to migrate at 37°C for approximately 6 hours followed by live 
video microscopy. VSVG-RUSH-GFP was released from the ER by addition of biotin and 
after 25 min VSVG carriers were tracked using ImageJ. Individual tracks are displayed on 
the representative images. Results are means ± SD from three independent experiments. 
Asterisks indicate statistically significant differences tested using Student’s T-test (** 
p<0.01).
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Figure 2. Models for the GM130-Cdc42 crosstalk
Schematic representation of two different models. On the left-hand side: GM130 acts as a 
scaffold for a Cdc42-GEF at the Golgi. In this case, a GEF should be located at the Golgi in 
a GM130 dependent manner. Upon GM130 depletion, the GEF is lost from the Golgi and 
subsequently, Cdc42-GTP doesn’t accumulate at the organelle. In the second scenario (right-
hand side), GM130 binds to an inhibitor of Cdc42, protecting the small GTPase from 
inactivation. If GM130 is lost, the inhibitor will bind to Cdc42 in places other than the 
Golgi, thereby preventing a GEF mediated activation of Cdc42. In this way, Cdc42-GTP 
will not be accumulated at the Golgi.
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Figure 3. Screening for GEFs that regulate the Golgi pool of Cdc42
(A) HEK293 cells were transfected with control or with the indicated siRNA. After 48h, 
cells were transfected with the plasmid encoding for the Cdc42-EM-FRET probe. After a 
further 24h the cells were fixed and mounted. FRET was measured as described in the 
Material and Methods section and FRET values are displayed as fold of control and are 
averages from the measurements of at least 30 cells per condition. Red bars represent CI95 
intervals (B) HeLa cells were transfected with plasmids encoding the indicated GEF. 24 h 
later, cells were lysed and the lysates were subjected to immunoprecipitation either with a 
GM130 antibody (+) or with protein G sepharose beads alone. “5% input” indicates lanes 
where 5% of the total material that was used in the IP is loaded. The immunoprecipitated 
material was eluted and subjected to SDS-PAGE followed by immunoblotting against the 
indicated proteins. (C) HeLa cells were plated on coverslips, then transfected with plasmids 
encoding the specified GEF. 24 h later, cells were fixed and immunostained for GM130 and 
Flag. Intensity plot corresponding to the region marked by a white arrow are shown on the 
right. Scale bar is 10 μm.
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Figure 4. The effect of GM130 on Cdc42 is dependent on RasGRF
(A) HeLa cells were lysed and the lysate was subjected to immunoprecipitation either with a 
GM130 antibody (+) or with protein G sepharose beads alone. “5% input” indicates lanes 
where 5% of the total material that was used in the IP is loaded. The immunoprecipitated 
material was eluted and subjected to SDS-PAGE followed by immunoblotting against the 
indicated protein. (B) Quantification of cells with RasGRF at the Golgi. (C) HeLa cells 
grown on glass cover slips were fixed followed by immunofluorescence staining of RasGRF 
and GM130. Images were acquired using a confocal laser-scanning microscope. The 
magnifications correspond to the areas inside the white squares. Scale bar is 25 μm. An 
intensity plot corresponding to the region marked by a white arrow is shown. (D) CHL cells 
were depleted of GM130 by siRNA transfection. After 72 h, cells were lysed and GST-
PAK1 was added to the lysate followed by pulldown with GSH-sepharose. The eluate was 
subjected to SDS-PAGE followed by immunoblotting against Cdc42 (Cdc42-GTP). 5% of 
the original lysate were subjected to SDS-PAGE followed by immunoblotting against Cdc42 
(Tot-Cdc42) and against GM130. Bar graph in the right panel represents a quantification of 
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the amount active Cdc42 (GTP-Cdc42) to total Cdc42. Results are means ± SD from three 
independent experiments. (E) RT-PCR of RasGRF2 comparing HeLa and CHL cells. (F) 
Cells were transfected with the indicated siRNA. After 72 h, a wound was made using a 
10μl pipette tip and cells were allowed to migrate and polarize for approximately 6 h at 37°C 
followed by fixation and immunofluorescence staining of Giantin to label the Golgi. The 
Golgi was counted as oriented towards the wound if its major mass was located in a 120° 
angle facing the wound edge. The red line shows the average orientation of the Golgi 
immediately after wounding. Results are means ± SD from three independent experiments. 
Asterisk indicates statistically significant differences using ANOVA with Newman-Keuls 
multiple comparison test (*p<0.05). (G) Caco-2 cells were transfected with siRNA against 
GM130, or RasGRF2, or with both siRNA. Cells were grown in Matrigel® for four days to 
allow cyst formation. Afterwards, cysts were stained for GM130 using immunofluorescence 
and for F-actin using fluorescent phalloidin as described in “Materials and Methods”. Cysts 
with a single lumen were counted as normal, while cysts with multiple or no lumen were 
counted as aberrant. The percentage of normal and aberrant cysts in each condition was 
counted from three independent experiments which are displayed in the bar graph in the 
lower panel. Results are means ± SD. Asterisk indicates statistically significant differences 
using ANOVA with Newman-Keuls multiple comparison test (*p<0.05; **p<0.01). Scale 
bar is 7.5 μm.
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Figure 5. The GM130-RasGRF complex is regulated by serum
(A) MCF7 cells were grown to confluency. Then, cells were serum-starved for 2 h followed 
by stimulation with 10% FCS for the indicated time points. Cell lysates were subjected to 
immunoprecipitation against GM130. The immunoprecipitate was subjected to SDS-PAGE 
followed by immunoblotting against the indicated proteins. (B) HeLa cells were transfected 
with control or GM130 siRNA 72h prior to the experiment. After 48 h, cells were 
transfected with the plasmid encoding for the Cdc42 Raichu probe. Cells were serum-
starved for 2 h followed by stimulation with 10% FCS for 0,1 and 5 min and FRET was 
measured as indicated in “Materials and Methods. Results are means ± SD from three 
independent experiments. Asterisks indicate statistically significant differences tested using 
ANOVA with Newman-Keuls multiple comparison test (*p<0.05). (C) HeLa cells were 
transfected with the indicated siRNA. After 48 h, cells were transfected with empty vector 
or with a plasmid encoding HA-tagged RasGRF1. After 24 h, cells were serum-starved for 2 
h followed by stimulation with 10% FCS for the indicated time points. Cell lysates were 
subjected to immunoprecipitation against HA. The immunoprecipitate was subjected to 
SDS-PAGE followed by immunoblotting against the indicated proteins.
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Figure 6. GM130 depletion increases Ras activity
(A) Working model: GM130 acts as a suppressor of RasGRF activity, thereby modulating 
the activities of Ras and Cdc42. According to this model, the knockdown of GM130 results 
in increased Ras activation and decreased Cdc42 activation. (B) HepG2 cells were 
transfected with the indicated siRNAs. After 72 h, cells were lysed and Ras pull-down was 
performed using GST-RBD. The eluate form the beads was subjected to SDS-PAGE 
followed by immunoblotting with a pan-Ras antibody (Ras-GTP). 5% of the original lysate 
was subjected to SDS-PAGE followed by immunoblotting against tubulin and GM130. Bar 
graph represents a quantification of the amount active Ras (Ras-GTP) normalized to tubulin. 
Results are means ± SD from three independent experiments. Asterisks indicate statistically 
significant differences tested using ANOVA with Newman-Keuls multiple comparison test 
(*p<0.05; ** p<0.01).
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Figure 7. Dysregulation of GM130 in human colon cancer
GM130 expression was measured by IHC on a Colon Progression TMA. (A) Graphic 
representation of the neoplastic evolution of colon carcinoma from the normal colon mucosa 
through the adenoma. (B) Bar graphs depicting the average expression level (± SD) of 
GM130 in Normal Colon Mucosa, Colon Tubulovillous Adenomas and Colon 
Adenocarcinomas or (C) the percentage of low and high GM130-expressing samples when 
using a cut off score value of 1.5 (differences are significant as assessed by Pearson χ2 
analysis P < 0.001). (D) Representative images of immunohistochemical staining for 
GM130. (E) Bar graphs depict the expression score of GM130 in 16 patients for which 
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matched normal and tumor tissue were available on the TMAs. GM130 is downregulated in 
colon cancer with respect to the normal colon mucosa in 14 out of 16 patients. (F) 
Representative core images of normal and tumor tissue from patient 14 and 19. Scale bar, 
100 μm
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